Allele-specific antibody reactivities to MSP-3 and protection from malaria [MIM-FO-44148]

Allele-specific antibody reactivities to MSP-3 and protection from malaria [MIM-FO-44148]

Detalles Bibliográficos
Autores principales:	Osier, F, Polley, S, Mwangi, T, Lowe, B, Conway, D, Marsh, K
Formato:	Conference item
Publicado:	2005

Ejemplares similares

Morbidity and co-morbidity in children with signs of severe malaria [MIM-JB-166260]
por: Berkley, J, et al.
Publicado: (2005)

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
por: Osier, F, et al.
Publicado: (2007)

Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
por: Osier, F, et al.
Publicado: (2010)

Allele frequency based tests of neutrality on eba-175 and ebl-1 in Plasmodium falciparum populations from Kenya and Thailand [MIM-FV-66780]
por: Verra, F, et al.
Publicado: (2005)

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
por: Polley, S, et al.
Publicado: (2006)

Allelic diversity of MSP1 and MSP2 repeat loci correlate with levels of malaria endemicity in Senegal and Nigerian populations
por: Mary A. Oboh, et al.
Publicado: (2021-01-01)

Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya.
por: Osier, F, et al.
Publicado: (2010)

Antibody acquisition against apical membrane antigen 1 in a cohort of children and the relationship to malaria exposure and protective immunity [MIM-CM-40691]
por: Mugyenyi, C, et al.
Publicado: (2005)

Lack of utility of clinical algorithms in malaria diagnosis among people of different age groups [MIM-TM-253344]
por: Mwangi, T, et al.
Publicado: (2005)

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
por: Osier, F, et al.
Publicado: (2008)

Peripheral blood dendritic cells in Kenyan children with acute falciparum malaria [MIM-BU-29088]
por: Urban, B, et al.
Publicado: (2005)

alpha plus Thalassaemia protects against malaria-induced anaemia in children living on the coast of Kenya [MIM-SW-139920]
por: Wambua, S, et al.
Publicado: (2005)

Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso
por: Anyirékun Fabrice Somé, et al.
Publicado: (2018-05-01)

Negative epistasis between the malaria-protective effects of alpha (+) thalassaemia and the sickle cell trait [MIM-TW-395505]
por: Williams, T, et al.
Publicado: (2005)

A detailed study of the kinetics of antibody responses to Plasmodium falciparum merozoite antigens [MIM-SK-10044]
por: Kinyanjui, S, et al.
Publicado: (2005)

Genomic miscellany and allelic frequencies of Plasmodium falciparum msp-1, msp-2 and glurp in parasite isolates.
por: Ibrar Ullah, et al.
Publicado: (2022-01-01)

<it>Plasmodium falciparum msp1</it>, <it>msp2 </it>and <it>glurp </it>allele frequency and diversity in sub-Saharan Africa
por: Snounou Georges, et al.
Publicado: (2011-04-01)

Genomic miscellany and allelic frequencies of Plasmodium falciparum msp-1, msp-2 and glurp in parasite isolates
por: Ibrar Ullah, et al.
Publicado: (2022-01-01)

Estimating the sequestered parasite load in severe malaria patients using both host and parasite markers [MIM-LO-23716]
por: Ochola, L, et al.
Publicado: (2005)

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
por: Polley, S, et al.
Publicado: (2004)

Nutritional status and malaria infections in children in malaria endemic area of Kenyan coast [MIM-AN-251750]
por: Nyakeriga, A, et al.
Publicado: (2005)

Identification of Alleles in the MSP1 Gene Related to Complicated Malaria in Patients Infected with Plasmodium falciparum in Southeast of Iran
por: Bentol Hoda Habibi-Shorkaei, et al.
Publicado: (2018-10-01)

Beninese Plant Extracts with Antiplasmodial Activity Select New Allele Variants Msp1 and Msp2 in Plasmodium falciparum
por: Hamirath O. Lagnika, et al.
Publicado: (2024-01-01)

INFLUENCE OF SICKLE CELL GENE ON THE ALLELIC DIVERSITY AT THE MSP-1 LOCUS OF PLASMODIUM FALCIPARUM IN ADULT PATIENTS WITH SEVERE MALARIA
por: Dilip Kumar Patel, et al.
Publicado: (2015-08-01)

The immunoepidemiology of malria [MIM-km-46728]
por: Marsh, K
Publicado: (2005)

The N-Terminal Region of Plasmodium falciparum MSP10 Is a Target of Protective Antibodies in Malaria and Is Important for PfGAMA/PfMSP10 Interaction
por: Hikaru Nagaoka, et al.
Publicado: (2019-11-01)

Low Allelic Variation of Plasmodium falciparum msp-1 and msp-2 among Gold Miners in Central Kalimantan Province, Indonesia
por: Heny Arwati, et al.
Publicado: (2023-03-01)

Investigating molecular mechanisms of erythrocyte invasion by Plasmodium falciparum in Kenya [MIM-SN-45262]
por: Nery, S, et al.
Publicado: (2005)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria
por: Murungi, L, et al.
Publicado: (2013)

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria.
por: Murungi, L, et al.
Publicado: (2013)

Genetic diversity and allele frequencies of Plasmodium falciparum msp1 and msp2 in parasite isolates from Bioko Island, Equatorial Guinea
por: Jiang-Tao Chen, et al.
Publicado: (2018-12-01)

Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria.
por: Bejon, P, et al.
Publicado: (2007)

Cohort study of the association of antibody levels to AMA1, MSP1<sub>19</sub>, MSP3 and GLURP with protection from clinical malaria in Ghanaian children
por: Bosomprah Samuel, et al.
Publicado: (2008-07-01)

Blood-Stage Malaria Vaccines : MSP1 19
por: Chakrit Hirunpetcharat
Publicado: (2015-02-01)

Marked variation in MSP-1<sub>19 </sub>antibody responses to malaria in western Kenyan highlands
por: Badu Kingsley, et al.
Publicado: (2012-03-01)

Safety and immunogenicity of the candidate malaria vaccines FP9 ME-TRAP and MVA METRAP in semi-immune adult males [MIM-OK-87312]
por: Kai, O, et al.
Publicado: (2005)

Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP)
por: Kangoye, D, et al.
Publicado: (2014)

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.
por: Kinyanjui, S, et al.
Publicado: (2009)

What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity
por: Kinyanjui, S, et al.
Publicado: (2009)

Broadly reactive antibodies specific for <it>Plasmodium falciparum</it> MSP-1<sub>19</sub> are associated with the protection of naturally exposed children against infection
por: Dent Arlene E, et al.
Publicado: (2012-08-01)